Angiogenic Factors in Diagnosis, Management, and Research in Preeclampsia

Overview

Journal Hypertension

Date 2013 Oct 30

PMID 24166749

Citations 43

Authors

Sarosh Rana

S Ananth Karumanchi

Marshall D Lindheimer

Affiliations

Soon will be listed here.

Citing Articles

Role of Immune Cells in Mediating the Effect of Lipids on Preeclampsia.

Dang C, Duan Y, Liu P, Liu J, Yu X, Wang J Reprod Sci. 2025; .

PMID: 40019643 DOI: 10.1007/s43032-025-01809-7.

Sensing Platform Based on Gold Nanoclusters and Nanoporous Anodic Alumina for Preeclampsia Detection.

Cantons J, Bachhuka A, Marsal L Biosensors (Basel). 2024; 14(12).

PMID: 39727876 PMC: 11674843. DOI: 10.3390/bios14120610.

Machine learning and bioinformatics framework integration reveal potential characteristic genes related to immune cell infiltration in preeclampsia.

Bai L, Guo Y, Gong J, Li Y, Huang H, Meng Y Front Physiol. 2023; 14:1078166.

PMID: 37389124 PMC: 10300062. DOI: 10.3389/fphys.2023.1078166.

Low-dose aspirin inhibits trophoblast cell apoptosis by activating the CREB/Bcl-2 pathway in pre-eclampsia.

Guo K, Li W, Wang Z, He L, Feng Y, Liu H Cell Cycle. 2022; 21(21):2223-2238.

PMID: 35792905 PMC: 9586659. DOI: 10.1080/15384101.2022.2092814.

Impact of reduced uterine perfusion pressure model of preeclampsia on metabolism of placenta, maternal and fetal hearts.

McClements L, Richards C, Patel N, Chen H, Sesperez K, Bubb K Sci Rep. 2022; 12(1):1111.

PMID: 35064159 PMC: 8782944. DOI: 10.1038/s41598-022-05120-2.

References

Menzies J, Magee L, Macnab Y, Ansermino J, Li J, Douglas M . Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes. Hypertens Pregnancy. 2007; 26(4):447-62. DOI: 10.1080/10641950701521742. View

Verdonk K, Visser W, Russcher H, Danser A, Steegers E, van den Meiracker A . Differential diagnosis of preeclampsia: remember the soluble fms-like tyrosine kinase 1/placental growth factor ratio. Hypertension. 2012; 60(4):884-90. DOI: 10.1161/HYPERTENSIONAHA.112.201459. View

Rana S, Schnettler W, Powe C, Wenger J, Salahuddin S, Cerdeira A . Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy. 2013; 32(2):189-201. PMC: 3744824. DOI: 10.3109/10641955.2013.784788. View

Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S . Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009; 361(9):858-67. DOI: 10.1056/NEJMoa0900428. View

Marcantoni C, Fogo A . A perspective on arterionephrosclerosis: from pathology to potential pathogenesis. J Nephrol. 2007; 20(5):518-24. View

Rolfo A, Attini R, Nuzzo A, Piazzese A, Parisi S, Ferraresi M . Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers. Kidney Int. 2012; 83(1):177-81. DOI: 10.1038/ki.2012.348. View

Kleinrouweler C, Wiegerinck M, Ris-Stalpers C, Bossuyt P, van der Post J, von Dadelszen P . Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG. 2012; 119(7):778-87. DOI: 10.1111/j.1471-0528.2012.03311.x. View

Koopmans C, Bijlenga D, Groen H, Vijgen S, Aarnoudse J, Bekedam D . Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009; 374(9694):979-988. DOI: 10.1016/S0140-6736(09)60736-4. View

Thangaratinam S, Gallos I, Meah N, Usman S, Ismail K, Khan K . How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2011; 90(6):564-73. DOI: 10.1111/j.1600-0412.2011.01111.x. View

10.

Schnettler W, Dukhovny D, Wenger J, Salahuddin S, Ralston S, Rana S . Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia. BJOG. 2013; 120(10):1224-32. PMC: 3744598. DOI: 10.1111/1471-0528.12259. View

11.

Thangaratinam S, Ismail K, Sharp S, Coomarasamy A, Khan K . Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. BJOG. 2006; 113(4):369-78. DOI: 10.1111/j.1471-0528.2006.00908.x. View

12.

Shibata E, Rajakumar A, Powers R, Larkin R, Gilmour C, Bodnar L . Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab. 2005; 90(8):4895-903. DOI: 10.1210/jc.2004-1955. View

13.

Staff A, Benton S, von Dadelszen P, Roberts J, Taylor R, Powers R . Redefining preeclampsia using placenta-derived biomarkers. Hypertension. 2013; 61(5):932-42. DOI: 10.1161/HYPERTENSIONAHA.111.00250. View

14.

Chaiworapongsa T, Romero R, Alpay Savasan Z, Kusanovic J, Ogge G, Soto E . Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. J Matern Fetal Neonatal Med. 2011; 24(10):1187-207. PMC: 3384532. DOI: 10.3109/14767058.2011.589932. View

15.

Levine R, Maynard S, Qian C, Lim K, England L, Yu K . Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004; 350(7):672-83. DOI: 10.1056/NEJMoa031884. View

16.

Stepan H, Unversucht A, Wessel N, Faber R . Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension. 2007; 49(4):818-24. DOI: 10.1161/01.HYP.0000258404.21552.a3. View

17.

Chaiworapongsa T, Romero R, Korzeniewski S, Cortez J, Pappas A, Tarca A . Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. J Matern Fetal Neonatal Med. 2013; 27(2):132-44. PMC: 4151529. DOI: 10.3109/14767058.2013.806905. View

18.

Noori M, Donald A, Angelakopoulou A, Hingorani A, Williams D . Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010; 122(5):478-87. DOI: 10.1161/CIRCULATIONAHA.109.895458. View

19.

Myatt L, Clifton R, Roberts J, Spong C, Wapner R, Thorp Jr J . Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?. BJOG. 2013; 120(10):1183-91. PMC: 4104359. DOI: 10.1111/1471-0528.12128. View

20.

Young B, Levine R, Salahuddin S, Qian C, Lim K, Karumanchi S . The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. J Matern Fetal Neonatal Med. 2009; 23(5):366-70. PMC: 3132879. DOI: 10.1080/14767050903184207. View